Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMATJL9)

Drug Name
SGN-B6A Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMATJL9

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Integrin beta-6 (ITGB6) TTKQSXZ ITB6_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT04389632) A Study of SGN-B6A in Advanced Solid Tumors. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Seagen.